IFNG and melanoma: Consequent heterogeneity in molecular content among cells can lead to different signaling responses, as measured by distinct IFN-γ and oncostatin M response in fibroblasts [47], and can lead to the presence of rare drug-resistant cells, such as those seen in melanoma [48].